Rocket Pharmaceuticals Inc (RCKT)
13.98
-0.84
(-5.67%)
USD |
NASDAQ |
Nov 15, 16:00
14.06
+0.08
(+0.57%)
After-Hours: 20:00
Rocket Pharmaceuticals Price to Book Value: 3.864 for Nov. 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 3.864 |
| November 14, 2024 | 4.097 |
| November 13, 2024 | 4.332 |
| November 12, 2024 | 4.431 |
| November 11, 2024 | 4.660 |
| November 08, 2024 | 4.824 |
| November 07, 2024 | 4.768 |
| November 06, 2024 | 4.860 |
| November 05, 2024 | 4.752 |
| November 04, 2024 | 4.647 |
| November 01, 2024 | 4.692 |
| October 31, 2024 | 4.600 |
| October 30, 2024 | 4.689 |
| October 29, 2024 | 4.794 |
| October 28, 2024 | 4.832 |
| October 25, 2024 | 4.708 |
| October 24, 2024 | 4.758 |
| October 23, 2024 | 4.860 |
| October 22, 2024 | 4.891 |
| October 21, 2024 | 4.868 |
| October 18, 2024 | 5.20 |
| October 17, 2024 | 5.092 |
| October 16, 2024 | 4.99 |
| October 15, 2024 | 4.609 |
| October 14, 2024 | 4.670 |
| Date | Value |
|---|---|
| October 11, 2024 | 4.728 |
| October 10, 2024 | 4.573 |
| October 09, 2024 | 4.595 |
| October 08, 2024 | 4.766 |
| October 07, 2024 | 4.634 |
| October 04, 2024 | 4.534 |
| October 03, 2024 | 4.437 |
| October 02, 2024 | 4.686 |
| October 01, 2024 | 4.730 |
| September 30, 2024 | 5.103 |
| September 27, 2024 | 4.366 |
| September 26, 2024 | 4.163 |
| September 25, 2024 | 4.366 |
| September 24, 2024 | 4.326 |
| September 23, 2024 | 4.678 |
| September 20, 2024 | 4.771 |
| September 19, 2024 | 5.052 |
| September 18, 2024 | 4.929 |
| September 17, 2024 | 5.156 |
| September 16, 2024 | 4.541 |
| September 13, 2024 | 4.648 |
| September 12, 2024 | 4.480 |
| September 11, 2024 | 4.501 |
| September 10, 2024 | 4.634 |
| September 09, 2024 | 4.667 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.255
Minimum
May 11 2022
14.78
Maximum
Dec 22 2020
4.284
Average
4.062
Median
Price to Book Value Benchmarks
| Apellis Pharmaceuticals Inc | 13.78 |
| NovaBay Pharmaceuticals Inc | 3.267 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9236 |
| Theriva Biologics Inc | 0.0528 |
Price to Book Value Related Metrics
| Price | 13.98 |
| Earnings Yield | -19.67% |
| Market Cap | 1.274B |